- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
BAVENCIO® Receives FDA Breakthrough Therapy Designation for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma.Bladder CancerApril 9, 2020
-
Inequity in selective referral to high-volume hospitals for genitourinary malignancies.Bladder CancerApril 9, 2020
-
Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis.Bladder CancerApril 9, 2020
-
The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion.Bladder CancerApril 9, 2020
-
Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis.Bladder CancerApril 9, 2020
-
Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis.Bladder CancerApril 9, 2020
-
The clinical study of en Bloc transurethral resection with 980 nm Laser for treatment of primary non-muscle invasive bladder cancer.Bladder CancerApril 8, 2020
-
Quantifying the effect of biopsy lateral decubitus patient positioning compared to supine prostate MRI scanning on prostate translocation and distortion.Bladder CancerApril 8, 2020
-
The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database.Bladder CancerApril 8, 2020
-
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.Bladder CancerApril 8, 2020
Beyond the Abstracts
-
Port-Site Metastasis and Atypical Recurrences after Robotic-Assisted Radical Cystectomy (RARC): An Updated Comprehensive and Systematic Review of Current Evidences - Beyond the AbstractBladder CancerApril 7, 2020
-
Patient-Reported Quality of Life Outcomes in Patients Treated for Muscle-Invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial - Beyond the AbstractBladder CancerMarch 26, 2020
-
Expression of L-Type Amino Acid Transporter 1 as a Molecular Target for Prognostic and Therapeutic Indicators in Bladder Carcinoma - Beyond the AbstractBladder CancerMarch 24, 2020
-
Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia - Beyond the AbstractBladder CancerMarch 20, 2020
-
Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions - Beyond the AbstractBladder CancerMarch 17, 2020
-
The Emerging Landscape of Germline Variants in Urothelial Carcinoma: Implications for Genetic Testing - Beyond the AbstractBladder CancerMarch 17, 2020
-
Highlighting the General Importance of Using Public Data Repositories for Hypothesis Generation and How It Changed Cancer Basic Research - Beyond the AbstractBladder CancerMarch 12, 2020
-
Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study - Beyond the AbstractBladder CancerFebruary 24, 2020
-
Predictive Biomarkers in Bladder Cancer - Beyond the AbstractBladder CancerFebruary 20, 2020
-
Photodynamic Versus White Light-Guided Treatment of Non-Muscle Invasive Bladder Cancer: A Study Protocol for a Randomised Trial of Clinical and Cost-Effectiveness - Beyond the AbstractBladder CancerFebruary 20, 2020